Soluble interleukin‐1 receptor accessory protein ameliorates collagen‐induced arthritis by a different mode of action from that of interleukin‐1 receptor antagonist
Open Access
- 28 June 2005
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (7) , 2202-2211
Abstract
Objective: To discern the mode of interleukin‐1 (IL‐1) inhibition of soluble IL‐1 receptor accessory protein (sIL‐1RAcP) by comparison with IL‐1 receptor antagonist (IL‐1Ra) in arthritis.Methods: Adenoviral vectors encoding either sIL‐1RAcP or IL‐1Ra were administered systemically before onset of collagen‐induced arthritis in DBA/1 mice. Anti–bovine type II collagen IgG and IL‐6 were quantified in serum. Proliferative response of splenic T cells was determined in the presence of sIL‐1RAcP or IL‐1Ra. The effect on IL‐1 inhibition of recombinant sIL‐1RAcP and IL‐1Ra was further examined in vitro, using NF‐κB luciferase reporter cell lines. Quantitative polymerase chain reaction was used to determine the relative messenger RNA expression of the IL‐1 receptors.Results: Adenoviral overexpression of both sIL‐1RAcP and IL‐1Ra resulted in amelioration of the collagen‐induced arthritis. Both IL‐1 antagonists reduced the circulating levels of antigen‐specific IgG2a antibodies, but only IL‐1Ra was able to inhibit lymphocyte proliferation. By using purified lymphocyte populations derived from NF‐κB reporter mice, we showed that sIL‐1RAcP inhibits IL‐1–induced NF‐κB activity in B cells but not T cells, whereas IL‐1Ra inhibited IL‐1 on both cell types. A study in a panel of NF‐κB luciferase reporter cells showed that the sIL‐1RAcP inhibits IL‐1 signaling on cells expressing either low levels of membrane IL‐1RAcP or high levels of IL‐1RII.Conclusion: We show that the sIL‐1RAcP ameliorated experimental arthritis without affecting T cell immunity, in contrast to IL‐1Ra. Our results provide data in support of receptor competition by sIL‐1RAcP as an explanation for the different mode of IL‐1 antagonism in comparison with IL‐1Ra.Keywords
This publication has 45 references indexed in Scilit:
- Effectiveness of the soluble form of the interleukin‐1 receptor accessory protein as an inhibitor of interleukin‐1 in collagen‐induced arthritisArthritis & Rheumatism, 2003
- Phenotypic differences in murine chondrocyte cell lines derived from mature articular cartilageOsteoarthritis and Cartilage, 2002
- A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritisGene Therapy, 2001
- Model of interaction of the IL‐1 receptor accessory protein IL‐1RAcP with the IL‐1β/IL‐1RI complexFEBS Letters, 2001
- A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonistNature, 1997
- TRAF6 is a signal transducer for interleukin-1Nature, 1996
- Anticytokine treatment of established type II collagen–induced arthritis in DBA/1 mice: A comparative study using anti‐TNFα, anti–IL‐1α/β, and IL‐1RaArthritis & Rheumatism, 1996
- Comparison of IL-1α effectiveness in activating murine pre-B and T cell linesCytokine, 1993
- cDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin SuperfamilyScience, 1988
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986